Resmed Inc risk profile
36 Normal where most of the sector sits
Measured 21 October 2026 from RMD's filed statements. Recomputed nightly.
36 (Normal), driven by Concentration at 58, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 28 | Normal | Stable | One-year price volatility — 29.4% |
| Operating pressure | 33 | Normal | Worsening | Costs outgrowing revenue — -0.1 percentage points |
| Cash conversion | 24 | Normal | Stable | Cash conversion — 1.19x |
| Leverage and coverage | 6 | Contained | Stable | Current ratio — 3.10x |
| Competitive position | 39 | Normal | Stable | R&D-intensity gap against peers — -9.7 percentage points |
| Concentration | 58 | Elevated | Stable | Geographic concentration — 3,970 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.